Effects of ambient temperature on COPD symptoms and exacerbations in the SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS) cohort Source: Virtual Congress 2021 – Environment and respiratory health Year: 2021
Predictors of dyspnoea prevalence: results from the BOLD study Source: Eur Respir J 2014; 43: 1610-1620 Year: 2014
Comparison of individual items of COPD Assessment Test (CAT) at baseline in the EMAX and IMPACT trials Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020
SGRQ-C distribution in the evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) cohort: Characteristics of COPD subjects with extreme score quintiles Source: Annual Congress 2010 - COPD: symptoms and staging Year: 2010
Heterogeneity in prevalence and underdiagnosis of COPD: Results from BOLD, EPI-SCAN, PLATINO, and PREPOCOL Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013
The Non-Invasive Ventilation Outcomes (NIVO) score in presumed COPD exacerbation without prior spirometry. Source: Virtual Congress 2020 – Non-invasive ventilation and nasal high flow: technical aspects and predictive scores Year: 2020
BODCAT index: Could we use it instead of BODE or BODEx to classify COPD severity? Source: International Congress 2014 – Clinical presentations Year: 2014
Disease awareness in COPD: Analyses of clinical parameters and patient-reported outcome from the SAT study Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020
LCI as an endpoint in COPD: Comparison with healthy controls, using SF6 and nitrogen washout Source: International Congress 2014 – Respiratory function: quality and new technologies Year: 2014
Effects of nintedanib in patients with IPF: subgroup analysis by Charlson Comorbidity Index (CCI) Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis? Year: 2020
COPD prevalence in Austria: results from the Burden of obstructive lung disease (BOLD) study Source: Eur Respir J 2006; 28: Suppl. 50, 446s Year: 2006
Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014
BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD – a cross-sectional study Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009
Scales of assesment in COPD. Correlation with clinical and functional parameters Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015
Activity monitor outcomes in COPD – Assessment of variability of 6 monitors as part of the IMI PROactive project Source: Annual Congress 2011 - Clinical physiology for clinical problems Year: 2011
Asthma control and asthma severity in relation to sleep disturbances: Results of the LifeGene study Source: International Congress 2018 – Clinical determinants of asthma and biomarkers Year: 2018
Effect of interval training on the BODE index, SF-36, EuroQol and St-George‘s Respiratory Questionnaires scores in COPD patients across GOLD stages I-IV Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012
Measurement of COPD severity: further validation of a survey-based instrument Source: Annual Congress 2007 - Epidemiology of COPD Year: 2007
Population Screening for COPD: A comparison of COPD Patient Screener and CAPTURE Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017
Assessment of severity and prognosis in COPD: moving beyond percent of predicted Source: Eur Respir J, 52 (2) 1801005; 10.1183/13993003.01005-2018 Year: 2018